SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Core Scientific, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

03/10/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP Number(s):

Names of Reporting Persons

Valiant Capital Management, L.P.

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 16,212,903.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 16,212,903.00

Aggregate Amount Beneficially Owned by Each Reporting Person

16,212,903.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

IA, PN

Comment for Type of Reporting Person: Percentage calculated based on 315,332,655 shares of Common Stock outstanding as of February 26, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.

SCHEDULE 13G

CUSIP Number(s):

Names of Reporting Persons

Valiant Capital Management, LLC

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 16,212,903.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 16,212,903.00

Aggregate Amount Beneficially Owned by Each Reporting Person

16,212,903.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

HC, OO

SCHEDULE 13G

CUSIP Number(s):

Names of Reporting Persons

Christopher R. Hansen

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

Sec Use Only

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 16,212,903.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 16,212,903.00

Aggregate Amount Beneficially Owned by Each Reporting Person

16,212,903.00

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

Percent of class represented by amount in row (9)

5.1 %

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Core Scientific, Inc.

(b)

Address of issuer's principal executive offices:

838 Walker Road, Suite 21-2105, Dover, DE 19904

Item 2.

(a)

Name of person filing:

Valiant Capital Management, L.P., a Delaware limited partnership ("VCM") Valiant Capital Management, LLC, a Delaware limited liability company ("VCM LLC") Christopher R. Hansen VCM is the investment adviser and general partner of private investment funds (collectively, the "Funds") and the investment adviser to other accounts. VCM LLC is the general partner of VCM. Mr. Hansen is the control person of VCM and VCM LLC. The reporting persons are filing this Schedule 13G jointly, but not as members of a group, and each disclaims membership in a group. Each reporting person also disclaims beneficial ownership of Common Stock except to the extent of that person's pecuniary interest therein.

(b)

Address or principal business office or, if none, residence:

394 Pacific Avenue, Floor 4, San Francisco, CA 94111

(c)

Citizenship:

See Item 4 of the cover sheet for each reporting person

(d)

Title of class of securities:

Common Stock

(e)

CUSIP No.:

21874A106

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

VCM: 16,212,903 VCM LLC: 16,212,903 Christopher R. Hansen: 16,212,903

(b)

Percent of class:

VCM: 5.1% VCM LLC: 5.1% Christopher R. Hansen: 5.1%

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

VCM: 0 VCM LLC: 0 Christopher R. Hansen: 0

(ii) Shared power to vote or to direct the vote:

VCM: 16,212,903 VCM LLC: 16,212,903 Christopher R. Hansen: 16,212,903

(iii) Sole power to dispose or to direct the disposition of:

VCM: 0 VCM LLC: 0 Christopher R. Hansen: 0

(iv) Shared power to dispose or to direct the disposition of:

VCM: 16,212,903 VCM LLC: 16,212,903 Christopher R. Hansen: 16,212,903

Item 5.

Ownership of 5 Percent or Less of a Class.

Not Applicable

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

The Funds hold the Common Stock for the benefit of their investors and have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Common Stock. No individual Fund's holdings of Common Stock are more than five percent of the outstanding Common Stock.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Valiant Capital Management, L.P.

Signature:	/s/ Michaela Beckman
Name/Title:	Chief Compliance Officer
Date:	03/12/2026

Valiant Capital Management, LLC

Signature:	/s/ Michaela Beckman
Name/Title:	Chief Compliance Officer
Date:	03/12/2026

Christopher R. Hansen

Signature:	/s/ Christopher R. Hansen
Name/Title:	Reporting person
Date:	03/12/2026

Exhibit Information

Exhibit 99 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

SEC Form SCHEDULE 13G filed by Core Scientific Inc.